Development of the hot compress to reduce vascular pain caused by peripheral intravenous oxaliplatin administration

Shizuoka Cancer Center0 个研究点目标入组 100 人开始时间: 2023年3月14日最近更新: 2024年11月6日

试验速览

暂无简介。

•Patient with vascular pain after L-OHP administration via peripheral venous route, warm compress was performed using existing method, and L-OHP is scheduled to be administered next course
•Eastern Cooperative Oncology Group Performance status 0 or 1
•No dementia or psychiatric disorders that could affect the evaluation
•Patients with vascular pain during L-OHP administration, with NRS evaluation and evaluation of warm compress care after performing existing methods
•Written informed consent

•Patients whose L-OHP dosage at the time of the existing method differs from the dosage of L-OHP at the time of the new method
•Steroids are mixed in the L-OHP solution
•Patients with vasculitis as a complication
•Patients with significant peripheral venous channeling difficulties
•Patients for whom the investigator determines that enrollment in the study is inappropriate

Efficacy of the hot compress

NRS evaluation of vascular pain caused by L-OHP administration when using the new hot compress cover
QOL evaluation of the feeling of using the new hot compress cover
Puncture side
Gauge of puncture needle used
Number of L-OHP doses at the start of the hot compress, actual L-OHP dose (mg/body) and dose
Puncture site
Whether Aqua gel was added or not
Surface temperature of the skin above the IV site
Presence of low temperature burns
Evaluation of peripheral sensory neuropathy
Contact dermatitis
NRS evaluation at the onset of vascular pain, worst case of vascular pain, and completion of L-OHP administration
Date and time
Patient's age, gender, medical history, body surface area, PS, and regimen details

发起方